Literature DB >> 17148559

The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men.

Thomas G Travison1, Andre B Araujo, Varant Kupelian, Amy B O'Donnell, John B McKinlay.   

Abstract

CONTEXT: Although it is known that serum testosterone (T) concentrations decline with age, the relative contributions of changes in health and lifestyle to that decline have not been adequately assessed.
OBJECTIVE: The objective of this study was to establish the relative importance of aging, health, and lifestyle in contributing to male T decline.
DESIGN: A prospective cohort study of health and endocrine functioning in randomly selected men with a baseline visit (T1, 1987-1989) and two follow-up visits (T2, 1995-1997; T3, 2002-2004) was conducted.
SETTING: An observational study of men residing in greater Boston, Massachusetts, was conducted. PARTICIPANTS: Participants included 1667 men aged 40 to 70 at baseline; follow-up was conducted on 947 (57%) and 584 (35%) at T2 and T3, respectively. MAIN OUTCOME MEASURES: Main outcome measures included total serum T, calculated free T (FT), and SHBG.
RESULTS: There were substantial declines in total serum T and FT levels associated with aging alone. However, many health and lifestyle changes were associated with accelerated decline. A 4- to 5-kg/m2 increase in body mass index or loss of spouse was associated with declines in total serum T comparable to that associated with approximately 10 yr of aging. Results were similar for FT, but fewer factors were associated with SHBG after age was taken into account.
CONCLUSIONS: Both chronological aging and changes in health and lifestyle factors are associated with declines in serum T. Comorbidities and lifestyle influences may be as strongly associated with declining T levels as is aging itself over the short- to midterm. These results suggest the possibility that age-related hormone decline may be decelerated through the management of health and lifestyle factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17148559     DOI: 10.1210/jc.2006-1859

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  94 in total

Review 1.  Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors:  Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 2.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

3.  Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham Heart Study.

Authors:  R Haring; V Xanthakis; A Coviello; L Sullivan; S Bhasin; H Wallaschofski; J M Murabito; R S Vasan
Journal:  Int J Androl       Date:  2012-05-29

Review 4.  The treatment of late-onset hypogonadism.

Authors:  Oktay Üçer; Bilal Gümüş
Journal:  Turk J Urol       Date:  2014-03-24

5.  An update on male hypogonadism therapy.

Authors:  Prasanth Surampudi; Ronald S Swerdloff; Christina Wang
Journal:  Expert Opin Pharmacother       Date:  2014-04-23       Impact factor: 3.889

Review 6.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

7.  The effect of testosterone on mood and well-being in men with erectile dysfunction in a randomized, placebo-controlled trial.

Authors:  M Spitzer; S Basaria; T G Travison; M N Davda; L DeRogatis; S Bhasin
Journal:  Andrology       Date:  2013-03-15       Impact factor: 3.842

8.  The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission.

Authors:  Thomas G Travison; Rebecca Shackelton; Andre B Araujo; Susan A Hall; Rachel E Williams; Richard V Clark; Amy B O'Donnell; John B McKinlay
Journal:  J Am Geriatr Soc       Date:  2008-05       Impact factor: 5.562

9.  Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample.

Authors:  Susan A Hall; Gretchen R Esche; Andre B Araujo; Thomas G Travison; Richard V Clark; Rachel E Williams; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

10.  The role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.

Authors:  Farid Saad; Louis J Gooren
Journal:  J Obes       Date:  2010-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.